Ipilimumab, Ibrutinib, and Nivolumab for the Treatment of Chronic Lymphocytic Leukemia and Richter Transformation

Clinical trial NCT04781855 · WITHDRAWN

Trial details

NCT number: NCT04781855
Sponsor: M.D. Anderson Cancer Center
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Hematopoietic and Lymphoid Cell Neoplasm Recurrent Chronic Lymphocytic Leukemia Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Small Lymphocytic Lymphoma Richter Syndrome

Start date: 2022-07-14
Primary completion: 2025-02-21
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.